| Identification | Back Directory | [Name]
6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) | [CAS]
1780390-76-2 | [Synonyms]
6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) | [Molecular Formula]
C17H15ClN4 | [MOL File]
1780390-76-2.mol | [Molecular Weight]
310.79 |
| Hazard Information | Back Directory | [Uses]
Senexin A is a useful intermediate. | [in vivo]
Senexin A hydrochloride (5 times daily) completely reverses the tumor-promoting effects of chemotherapy. Senexin A hydrochloride had no significant toxicity to body weight, organ weights, or blood cell counts in C57BL/6 mice during treatment. Senexin A hydrochloride treatment significantly improves A549/MEF tumor response to Doxorubicin (HY-15142A)[1]. | [IC 50]
CDK8: 280 nM (IC50); CDK8: 0.83 μM (Kd); CDK19: 0.31 μM (Kd) | [storage]
Store at +4°C |
|
|